Stocks to Watch: Bharti Airtel, Gland Pharma, Zydus Lifesciences and more

Bharti Airtel Ltd | The company reported a 14.2% sequential rise in consolidated net profit to ₹6,791 crore for Q2 FY26, surpassing CNBC-TV18’s estimate of ₹6,600 crore. Revenue climbed 5.4% QoQ to ₹52,145 crore, while EBITDA grew 6.2% to ₹29,561 cro…

Leave a Reply

Your email address will not be published. Required fields are marked *